Skip to main content
SpringerLink
Log in
Book cover

Diabetes-Therapie – informiert entscheiden pp 75–77Cite as

Fall 20: Spätschäden – 58 Jahre, ♀, DM Typ 1, drohende Dialyse

  • Chapter
  • First Online:

  • 2273 Accesses

Zusammenfassung

Eine 58-jährige Patientin, jetzt einem Kreatinin von 4,5 mg/dl, einem Harnstoff von 150 mg/dl, Übelkeit und Erbrechen, einem Body Mas Index von 28, Blutdruck von 150/95 mm Hg, einem LDL von 180 mg/dl, einer Makroalbuminurie und einem HbA1c von 8,0 %. Wie kann man die Dialyse hinauszögern?

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   29.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • ACCORD Study Group, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F (2010) Effects of intensive blood-pressure control in type 2 diabetes mellitus. New Engl J Med 362(17):1575–1585. https://doi.org/10.1056/NEJMoa1001286

    Article  CAS  Google Scholar 

  • ACCORD Study Group (2014) Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study. Lancet Diabetes Endocrinol 2(10):793–800. https://doi.org/10.1016/S2213-8587(14)70155-X

    Article  Google Scholar 

  • Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R, Investigators S (2011) The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 377(9784):2181–2192. https://doi.org/10.1016/S0140-6736(11)60739-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S, Investigators RS (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New Engl J Med 345(12):861–869. https://doi.org/10.1056/NEJMoa011161

    Article  CAS  PubMed  Google Scholar 

  • Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. New Engl J Med 329(20):1456–1462. https://doi.org/10.1056/nejm199311113292004

    Article  CAS  Google Scholar 

  • The DCCT/EDIC Research Group, Boer IH de, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B (2011) Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. New Engl J Med 365(25):2366–2376. https://doi.org/10.1056/NEJMoa1111732

    Article  CAS  Google Scholar 

  • Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G, Ritz E, German D, Dialysis Study I (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. New Engl J Med 353(3):238–248. https://doi.org/10.1056/nejmoa043545

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Deutschland

    Lars Kihm

Authors
  1. Lars Kihm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lars Kihm .

Editor information

Editors and Affiliations

  1. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Germany

    Lars Kihm

  2. Abteilung Innere Medizin I, Medizinische Universitätsklinik, Heidelberg, Germany

    Stefan Kopf

  3. Zentrum für Innere Medizin I und klinische Chemie, Medizinische Universitätsklinik, Heidelberg, Germany

    Peter Nawroth

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kihm, L. (2018). Fall 20: Spätschäden – 58 Jahre, ♀, DM Typ 1, drohende Dialyse. In: Kihm, L., Kopf, S., Nawroth, P. (eds) Diabetes-Therapie – informiert entscheiden. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55972-7_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55972-7_20

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55971-0

  • Online ISBN: 978-3-662-55972-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation